• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ:NRSN)

    1.180 -0.060 (-4.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 254,122
    Open 1.220
    Bid (Size) 1.150 (5)
    Ask (Size) 1.230 (2)
    Prev. Close 1.240
    Today's Range 1.150 - 1.240
    52wk Range 0.8000 - 2.600
    Shares Outstanding 23,228,941
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Wednesday's session: top gainers and losers
    Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill

    Performance

    YTD
    +2.6%
    +2.6%
    1 Month
    +3.2%
    +3.2%
    3 Month
    -46.4%
    -46.4%
    6 Month
    +8.6%
    +8.6%
    1 Year
    -5.6%
    -5.6%

    More News

    Read More
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
    Via Chartmill
    These stocks are moving in today's session
    Via Chartmill
    The market is filled with gapping stocks in Friday's session.
    Via Chartmill
    NeuroSense Inches Closer to Pharma Partnership as Canadian Regulatory Progress Turns Heads
    Via News Direct
    Topics Regulatory Compliance
    Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights
    Via Benzinga
    This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
    Via Benzinga
    NeuroSense Therapeutics is on Verge of Potential Blockbuster Pharma Deal as ALS Drug Shows 58% Survival Improvement
    Via News Direct
    Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
    From Market News Alerts
    Via Business Wire
    Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
    Via News Direct
    Topics Regulatory Compliance
    PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
    From PESG Research
    Via Business Wire
    EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
    Via Benzinga
    NeuroSense Advances Plans For Early Commercialization Of Potentially Groundbreaking ALS Treatment In Canada, Targeting A $100M+ Market
    Via News Direct
    EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug
    Via Benzinga
    NRSN Stock Earnings: NeuroSense Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
    Via Benzinga
    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    US Stocks Higher; Private Payrolls Rise By 103,000 In November
    Via Benzinga
    Topics Stocks
    Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Frequently Asked Questions

    Is NeuroSense Therapeutics Ltd. - Ordinary Shares publicly traded?
    Yes, NeuroSense Therapeutics Ltd. - Ordinary Shares is publicly traded.
    What exchange does NeuroSense Therapeutics Ltd. - Ordinary Shares trade on?
    NeuroSense Therapeutics Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares?
    The ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares is NRSN on the Nasdaq Stock Market
    What is the current price of NeuroSense Therapeutics Ltd. - Ordinary Shares?
    The current price of NeuroSense Therapeutics Ltd. - Ordinary Shares is 1.180
    When was NeuroSense Therapeutics Ltd. - Ordinary Shares last traded?
    The last trade of NeuroSense Therapeutics Ltd. - Ordinary Shares was at 09/25/25 04:00 PM ET
    What is the market capitalization of NeuroSense Therapeutics Ltd. - Ordinary Shares?
    The market capitalization of NeuroSense Therapeutics Ltd. - Ordinary Shares is 27.41M
    How many shares of NeuroSense Therapeutics Ltd. - Ordinary Shares are outstanding?
    NeuroSense Therapeutics Ltd. - Ordinary Shares has 27M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.